Jennifer Hasvold1, Michael Sjoding2, Kyle Pohl3, Colin Cooke4, Robert C Hyzy2. 1. Department of Internal Medicine, University of Michigan, Ann Arbor, MI. Electronic address: hasvold@gmail.com. 2. Division of Pulmonary & Critical Care Medicine, Department of Internal Medicine, University of Michigan, Ann Arbor, MI. 3. Department of Internal Medicine, University of Michigan, Ann Arbor, MI. 4. Division of Pulmonary & Critical Care Medicine, Department of Internal Medicine, University of Michigan, Ann Arbor, MI; Center for Healthcare Outcomes & Policy, Institute for Healthcare Innovation & Policy, University of Michigan, Ann Arbor, MI.
Abstract
PURPOSE: The purpose of the study is to describe the role of human metapneumovirus (hMPV) infection in critical illness and acute respiratory distress syndrome (ARDS). MATERIALS AND METHODS: We collected clinical and demographic information from a retrospective chart review, comparing patients with and without an intensive care unit (ICU) admission. Among patients admitted to the ICU, we assessed whether hMPV was "unlikely," "possibly," or "likely" the reason for ICU admission, based on a prespecified definition, and whether the patient met criteria for ARDS. RESULTS: We identified 128 hospitalized adults with hMPV infection. Forty hospitalized patients (31%) with hMPV infection required admission to the ICU. Among patients cared for in the ICU, hMPV was "possibly" the reason for ICU admission in 55% of patients and "likely" the reason in 38%. Forty-eight percent of ICU patients met criteria for ARDS. Although most patients admitted to the ICU had significant comorbidities or were immunosuppressed, 6 patients requiring ICU admission had more minor comorbidities and no underlying immunosuppression. CONCLUSIONS: Although most patients hospitalized with hMPV had chronic cardiac or pulmonary disease, hMPV can also be associated serious respiratory illness and ARDS in adult patients without significant comorbidities or immunosuppression.
PURPOSE: The purpose of the study is to describe the role of human metapneumovirus (hMPV) infection in critical illness and acute respiratory distress syndrome (ARDS). MATERIALS AND METHODS: We collected clinical and demographic information from a retrospective chart review, comparing patients with and without an intensive care unit (ICU) admission. Among patients admitted to the ICU, we assessed whether hMPV was "unlikely," "possibly," or "likely" the reason for ICU admission, based on a prespecified definition, and whether the patient met criteria for ARDS. RESULTS: We identified 128 hospitalized adults with hMPV infection. Forty hospitalized patients (31%) with hMPV infection required admission to the ICU. Among patients cared for in the ICU, hMPV was "possibly" the reason for ICU admission in 55% of patients and "likely" the reason in 38%. Forty-eight percent of ICU patients met criteria for ARDS. Although most patients admitted to the ICU had significant comorbidities or were immunosuppressed, 6 patients requiring ICU admission had more minor comorbidities and no underlying immunosuppression. CONCLUSIONS: Although most patients hospitalized with hMPV had chronic cardiac or pulmonary disease, hMPV can also be associated serious respiratory illness and ARDS in adult patients without significant comorbidities or immunosuppression.
Authors: Guy Boivin; Yacine Abed; Gilles Pelletier; Louisette Ruel; Danielle Moisan; Stéphanie Côté; Teresa C T Peret; Dean D Erdman; Larry J Anderson Journal: J Infect Dis Date: 2002-10-08 Impact factor: 5.226
Authors: M E Hamelin; S Côté; J Laforge; N Lampron; J Bourbeau; K Weiss; R Gilca; G DeSerres; G Boivin Journal: Clin Infect Dis Date: 2005-07-15 Impact factor: 9.079
Authors: V Marco Ranieri; Gordon D Rubenfeld; B Taylor Thompson; Niall D Ferguson; Ellen Caldwell; Eddy Fan; Luigi Camporota; Arthur S Slutsky Journal: JAMA Date: 2012-06-20 Impact factor: 56.272
Authors: B G van den Hoogen; J C de Jong; J Groen; T Kuiken; R de Groot; R A Fouchier; A D Osterhaus Journal: Nat Med Date: 2001-06 Impact factor: 53.440
Authors: E Cuquemelle; F Soulis; D Villers; F Roche-Campo; C Ara Somohano; M Fartoukh; A Kouatchet; B Mourvillier; J Dellamonica; W Picard; M Schmidt; T Boulain; C Brun-Buisson Journal: Intensive Care Med Date: 2011-03-03 Impact factor: 17.440
Authors: Frank Esper; Richard A Martinello; Derek Boucher; Carla Weibel; David Ferguson; Marie L Landry; Jeffrey S Kahn Journal: J Infect Dis Date: 2004-04-02 Impact factor: 5.226
Authors: Holly M Biggs; Chris A Van Beneden; Katie Kurkjian; Miwako Kobayashi; Teresa C T Peret; John T Watson; Eileen Schneider; Susan I Gerber; Jayashree Ravishankar Journal: Clin Infect Dis Date: 2020-06-10 Impact factor: 9.079
Authors: Michael A Matthay; Rachel L Zemans; Guy A Zimmerman; Yaseen M Arabi; Jeremy R Beitler; Alain Mercat; Margaret Herridge; Adrienne G Randolph; Carolyn S Calfee Journal: Nat Rev Dis Primers Date: 2019-03-14 Impact factor: 52.329
Authors: Ali Mohammed Alsuheel; Abdelwahid Saeed Ali; Ahmed Musa Al-Hakami; Ayed Abdullah Shati; Harish C Chandramoorthy; Saleh Mohammed Al-Qahtani Journal: Saudi J Med Med Sci Date: 2019-04-12
Authors: Jung Wan Yoo; Sunmi Ju; Seung Jun Lee; Min Chul Cho; Yu Ji Cho; Yi Yeong Jeong; Jong Deog Lee; Ho Choel Kim Journal: Tuberc Respir Dis (Seoul) Date: 2019-10